Health Insurance - Coverage for Specialty Drugs

Added multiple sponsors to the bill, including Delegates Alston, Bagnall, Bhandari, Chisholm, Cullison, Guzzone, Hill, Hutchinson, Kaiser, Kerr, Kipke, Lopez, Martinez, M. Morgan, Pena-Melnyk, Reilly, Rosenberg, Ross, Szeliga, Taveras, White Holland, Woods, and Woorman.

Added committee report noting the bill was adopted and read a second time on March 1, 2025.

Reorganized the bill structure to include Section 15-847(h) and 15-847.2 in the header, clarifying the relationship between these sections.

Added new subsection (H) stating that this section may not be construed to supersede the authority of the Health Services Cost Review Commission to set rates for specialty drugs administered in settings regulated by that commission.

Modified subsection (D) regarding reimbursement rates to clarify that rates may not exceed the rate applicable to a designated specialty pharmacy unless otherwise agreed to by the covered, in-network provider, and the entity.